Best EDC Systems for Phase 1 Trials

Best EDC systems for Phase 1 trials: compare options for rapid build, eConsent, ePRO, and 21 CFR Part 11–aligned controls without enterprise overhead.

21 CFR Part 11–aligned · HIPAA-aligned security · No credit card required

Overview

Best EDC Systems for Phase 1 Trials

Phase 1 trial teams need EDC systems that support rapid build, frequent amendments, and dense safety and PK capture without enterprise implementation or pricing that doesn’t fit small cohorts. This page is for sponsors and CROs actively comparing EDC vendors or looking for the best fit for Phase 1 trials. Capture is built for Phase 1: a single platform for EDC, eConsent, ePRO, and safety with 21 CFR Part 11–aligned controls and HIPAA-aligned security, rapid build and amendments, and documentation to support sponsor validation when required.

What to look for in EDC for Phase 1 trials

Phase 1 trials need agility: fast build, easy amendments, and one system for consent, CRFs, and safety. The best EDC systems for Phase 1 avoid enterprise implementation timelines and per-seat pricing that doesn’t scale with small cohorts. Transparent comparison criteria include implementation speed, pricing fit, eConsent/ePRO integration, safety and PK workflow support, and documentation for sponsor validation. Capture is built for Phase 1 with these attributes.

Comparison criteria for Phase 1 EDC

  • Implementation speed and time to first patient or first dose
  • Pricing model: fit for small Phase 1 cohorts
  • Integrated eConsent, ePRO, and EDC in one platform and one audit trail
  • Support for safety, PK, and AE capture with full audit trail
  • 21 CFR Part 11–aligned controls and HIPAA-aligned security
  • Documentation and support for sponsor validation; flexible amendments

Why Phase 1 teams compare EDC options

  • Long implementation cycles that delay first-patient-in or first dose
  • Pricing and contracts geared toward large trials
  • Heavy change control for protocol and form amendments
  • Need for rapid build and flexibility without enterprise overhead

Where Capture fits for Phase 1 trials

  • Single platform for EDC, eConsent, ePRO, and safety; one audit trail
  • Rapid study build and deployment; flexible amendments for Phase 1
  • Safety and AE workflows with 21 CFR Part 11–aligned controls and HIPAA-aligned security
  • Documentation to support sponsor validation (Enterprise); pricing that scales with cohort size
  • Built for Phase 1; compare options or book a demo to evaluate fit

Related

EDC for Phase 1 clinical trialsEDC for Phase 1a clinical trialsFeatures

FAQ

Questions we hear a lot

Who is this page for?
Sponsors and CROs actively comparing EDC vendors or looking for the best fit for Phase 1 trials: rapid build, eConsent, ePRO, and 21 CFR Part 11–aligned controls without enterprise overhead.
What should I compare when evaluating EDC for Phase 1?
Consider implementation speed, pricing fit for small cohorts, whether eConsent and ePRO are integrated, safety and PK workflow support, 21 CFR Part 11–aligned controls, and support for sponsor validation. Capture is built for Phase 1 with these attributes.
Is Capture suitable for Phase 1 trials?
Yes. Capture is designed for Phase 1 and early-phase trials. You get EDC, eConsent, ePRO, and safety in one platform with 21 CFR Part 11–aligned controls. Many teams use Capture for Phase 1 and Phase 1a studies.

Ready to see Capture in action?

Explore the platform with a free sandbox. No sales call required.